|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rugge M, Fassan M and Graham DY:
Epidemiology of gastric cancer. Gastric Cancer Springer. 23–34.
2015. View Article : Google Scholar
|
|
4
|
Feng H, Weng X, Wang Z and Zhang D:
Relationship between living, dietary habits and gastric cancer by
case-control study in residents of Zhangzhou City. Strait J Prev
Med. 3:12–14. 2016.(In Chinese).
|
|
5
|
González CA, Sala N and Rokkas T: Gastric
cancer: Epidemiologic aspects. Helicobacter. 18 Suppl 1:S34–S38.
2013. View Article : Google Scholar
|
|
6
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
ENCODE Project Consortium, ; Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson JM, Edwards S, Shoemaker D and
Schadt EE: Dark matter in the genome: Evidence of widespread
transcription detected by microarray tiling experiments. Trends
Genet. 21:93–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mattick JS, Amaral PP, Dinger ME, Mercer
TR and Mehler MF: RNA regulation of epigenetic processes.
Bioessays. 31:51–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Q, Zhai YY, Dai JH, Li KY, Deng Q and
Han ZG: SAMD9L inactivation promotes cell proliferation via
facilitating G1-S transition in hepatitis B virus-associated
hepatocellular carcinoma. Int J Biol Sci. 10:807–816. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng W, Si S, Zhang Q, Li C, Zhao F, Wang
F, Yu J and Ma R: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate gastric cancer progression. J Exp Clin
Cancer Res. 34:792015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ
and Hu JH: Long non-coding RNA CCAT2 is up-regulated in gastric
cancer and associated with poor prognosis. Int J Clin Exp Pathol.
8:779–785. 2015.PubMed/NCBI
|
|
18
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W and Chen Jf: Long noncoding RNA
ANRIL indicates a poor prognosis of gastric cancer and promotes
tumor growth by epigenetically silencing of miR-99a/miR-449a.
Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lan WG, Xu DH, Xu C, Ding CL, Ning FL,
Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA
ANRIL inhibits the development of multidrug resistance in gastric
cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li L, Zhang L, Zhang Y and Zhou F:
Increased expression of LncRNA BANCR is associated with clinical
progression and poor prognosis in gastric cancer. Biomed
Pharmacother. 72:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Servant N, Roméjon J, Gestraud P, La Rosa
P, Lucotte G, Lair S, Bernard V, Zeitouni B, Coffin F,
Jules-Clément G, et al: Bioinformatics for precision medicine in
oncology: Principles and application to the SHIVA clinical trial.
Front Genet. 5:1522014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tao J, Deng NT, Ramnarayanan K, Huang B,
Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J, et al: CD44-SLC1A2
gene fusions in gastric cancer. Sci Transl Med. 3:77ra302011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muratani M, Deng N, Ooi WF, Lin SJ, Xing
M, Xu C, Qamra A, Tay ST, Malik S, Wu J, et al: Nanoscale chromatin
profiling of gastric adenocarcinoma reveals cancer-associated
cryptic promoters and somatically acquired regulatory elements. Nat
Commun. 5:43612014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chia NY, Deng N, Das K, Huang D, Hu L, Zhu
Y, Lim KH, Lee MH, Wu J, Sam XX, et al: Regulatory crosstalk
between lineage-survival oncogenes KLF5, GATA4 and GATA6
cooperatively promotes gastric cancer development. Gut. 64:707–719.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lei Z, Tan IB, Das K, Deng N, Zouridis H,
Pattison S, Chua C, Feng Z, Guan YK, Ooi CH, et al: Identification
of molecular subtypes of gastric cancer with different responses to
PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology.
145:554–565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li H, Yu B, Li J, Su L, Yan M, Zhang J, Li
C, Zhu Z and Liu B: Characterization of differentially expressed
genes involved in pathways associated with gastric cancer. PLoS
One. 10:e01250132015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Holbrook JD, Parker JS, Gallagher KT,
Halsey WS, Hughes AM, Weigman VJ, Lebowitz PF and Kumar R: Deep
sequencing of gastric carcinoma reveals somatic mutations relevant
to personalized medicine. J Transl Med. 9:1192011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng L, Wang P, Yang S, Yang Y and Zhang
Q, Zhang W, Xiao H, Gao H and Zhang Q: Identification of genes with
a correlation between copy number and expression in gastric cancer.
BMC Med Genomics. 5:142012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng L, Yang S, Yang Y, Zhang W, Xiao H,
Gao H, Deng X and Zhang Q: Global gene expression and functional
network analysis of gastric cancer identify extended pathway maps
and GPRC5A as a potential biomarker. Cancer Lett. 326:105–113.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng L and Zhang Q, Yang S, Yang Y, Zhang
W, Gao H, Deng X and Zhang Q: A 4-gene panel as a marker at
chromosome 8q in Asian gastric cancer patients. Genomics.
102:323–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo
J, Ni Z, Zhang M, Kong X, Hoffman LL, et al: An integrated
transcriptomic and computational analysis for biomarker
identification in gastric cancer. Nucleic Acids Res. 39:1197–1207.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui J, Li F, Wang G, Fang X, Puett JD and
Xu Y: Gene-expression signatures can distinguish gastric cancer
grades and stages. PLoS One. 6:e178192011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Larkin MA, Blackshields G, Brown NP,
Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm
A, Lopez R, et al: Clustal W and Clustal X version 2.0.
Bioinformatics. 23:2947–2948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi
H, Cheng L and Sun J: Relapse-related long non-coding RNA signature
to improve prognosis prediction of lung adenocarcinoma. Oncotarget.
7:29720–29738. 2016.PubMed/NCBI
|
|
41
|
Sun C, Jiang H, Sun Z, Gui Y and Xia H:
Identification of long non-coding RNAs biomarkers for early
diagnosis of myocardial infarction from the dysregulated
coding-non-coding co-expression network. Oncotarget. 7:73541–73551.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhai X, Xue Q, Liu Q, Guo Y and Chen Z:
Colon cancer recurrence-associated genes revealed by WGCNA
co-expression network analysis. Mol Med Rep. 16:6499–6505. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. Bmc
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang P, Wang Y, Hang B, Zou X and Mao JH:
A novel gene expression-based prognostic scoring system to predict
survival in gastric cancer. Oncotarget. 7:55343–55351.
2016.PubMed/NCBI
|
|
45
|
Goeman JJ: L1 penalized estimation in the
Cox proportional hazards model. Biom J. 52:70–84. 2010.PubMed/NCBI
|
|
46
|
Knafl GJ, Dixon JK, O'Malley JP, Grey M,
Deatrick JA, Gallo A and Knafl KA: Scale development based on
likelihood cross-validation. Stat Methods Med Res. 21:599–619.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qi C, Hong L, Cheng Z and Yin Q:
Identification of metastasis-associated genes in colorectal cancer
using metaDE and survival analysis. Oncol Lett. 11:568–574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li
N, Zhu ZD, Zhou B, Liu XY, Liu RF, et al: Exome sequencing of
hepatitis B virus-associated hepatocellular carcinoma. Nat Genet.
44:1117–1121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tilford CA and Siemers NO: Gene set
enrichment analysis. Methods Mol Biol. 563:99–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Heitzmann D, Grahammer F, von Hahn T,
Schmitt-Gräff A, Romeo E, Nitschke R, Gerlach U, Lang HJ, Verrey F,
Barhanin J and Warth R: Heteromeric KCNE2/KCNQ1 potassium channels
in the luminal membrane of gastric parietal cells. J Physiol.
561:547–557. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Abbott GW and Roepke TK: KCNE2 and gastric
cancer: Bench to bedside. Oncotarget. 7:17286–17287. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang J, Zhao Z, Zu C, Hu H, Shen H, Zhang
M and Wang J: Atrial natriuretic peptide modulates the
proliferation of human gastric cancer cells via KCNQ1 expression.
Oncol Lett. 6:407–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu X, Chen Z, Zhao X, Huang M, Wang C,
Peng W, Yin J, Li J, He G, Li X and Zhu X: Effects of IGF2BP2,
KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic
gastric cancer treated with EOF regimen. Pharmacogenomics.
16:959–970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Than BL, Goos JA, Sarver AL, O'Sullivan
MG, Rod A, Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y, et
al: The role of KCNQ1 in mouse and human gastrointestinal cancers.
Oncogene. 33:3861–3868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei Y, Wang T, Song H, Tian L, Lyu G, Zhao
L and Xue Y: C-C motif chemokine 22 ligand (CCL22) concentrations
in sera of gastric cancer patients are related to peritoneal
metastasis and predict recurrence within one year after radical
gastrectomy. J Surg Res. 211:266–278. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang J, Zhou Y and Yang Y: CCR7 pathway
induces epithelial-mesenchymal transition through up-regulation of
Snail signaling in gastric cancer. Med Oncol. 32:4672015.PubMed/NCBI
|
|
57
|
Wang WN, Chen Y, Zhang YD and Hu TH: The
regulatory mechanism of CCR7 gene expression and its involvement in
the metastasis and progression of gastric cancer. Tumour Biol.
34:1865–1871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang W, Sun J, Li F, Li R, Gu Y, Liu C,
Yang P, Zhu M, Chen L, Tian W, et al: A frequent somatic mutation
in CD274 3′-UTR leads to protein over-expression in gastric cancer
by disrupting miR-570 binding. Hum Mutat. 33:480–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wei Y, Lin C, Li H, Xu Z, Wang J, Li R,
Liu H, Zhang H, He H and Xu J: CXCL13 expression is prognostic and
predictive for postoperative adjuvant chemotherapy benefit in
patients with gastric cancer. Cancer Immunol Immunother.
67:261–269. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ding Y, Shen J, Zhang G, Chen X, Wu J and
Chen W: CD40 controls CXCR5-induced recruitment of myeloid-derived
suppressor cells to gastric cancer. Oncotarget. 6:38901–38911.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tian WY, Chen WC, Li R and Liu L: Markers
CD40, VEGF, AKT, PI3K, and S100 correlate with tumor stage in
gastric cancer. Onkologie. 36:26–31. 2013.PubMed/NCBI
|
|
62
|
Dong Z, Fu S, Xu X, Yang Y, Du L, Li W,
Kan S, Li Z, Zhang X, Wang L, et al: Leptin-mediated regulation of
ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell
migration. Br J Cancer. 110:1801–1810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ,
Chi NH, Shih YT, Chen GH and Lin JT: Plasma matrix
metalloproteinase-9 level is better than serum matrix
metalloproteinase-9 level to predict gastric cancer evolution. Clin
Cancer Res. 13:2054–2060. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chen SW, Zhang Q, Xu ZF, Wang HP, Shi Y,
Xu F, Zhang WJ, Wang P and Li Y: HOXC6 promotes gastric cancer cell
invasion by upregulating the expression of MMP9. Mol Med Rep.
14:3261–3268. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xia Q, Bai QR, Dong M, Sun X, Zhang H, Cui
J, Xi H, Hu XL, Shen Q and Chen L: Interaction between gastric
carcinoma cells and neural cells promotes perineural invasion by a
pathway involving VCAM1. Dig Dis Sci. 60:3283–3292. 2015.
View Article : Google Scholar : PubMed/NCBI
|
